vTv Therapeutics Inc (VTVT)
23.70
-0.07
(-0.29%)
USD |
NASDAQ |
May 31, 16:00
23.95
+0.25
(+1.05%)
After-Hours: 20:00
vTv Therapeutics Revenue (Annual)
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2022 | 2.018M |
| December 31, 2021 | 4.005M |
| December 31, 2020 | 6.414M |
| December 31, 2019 | 2.764M |
| December 31, 2018 | 12.43M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.291M |
| December 31, 2016 | 0.634M |
| December 31, 2015 | 0.519M |
| December 31, 2014 | 1.549M |
| December 31, 2013 | 0.976M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
2.018M
Minimum
2022
6.414M
Maximum
2020
3.800M
Average
3.384M
Median
Revenue (Annual) Benchmarks
| Amgen Inc | 28.19B |
| Eli Lilly and Co | 34.12B |
| Altimmune Inc | 0.426M |
| Viking Therapeutics Inc | -- |
| Rhythm Pharmaceuticals Inc | 77.43M |